Eden Priaire, Minnesota (PRWEB) July 12, 2012
Yesterday the Federal Trade Commission (FTC) put out a press release providing homeowners and consumers guidelines on how to respond to robocalls and stay away from mortgage relief scammers. Fairly merely, there are 4 basic guidelines mentioned:

1)
New York, New York (PRWEB) June 02, 2013
Court documents indicate that more than 1,500 Actos lawsuit claims alleging bladder cancer are now pending in a federal litigation underway in the U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports.

According to court records, an update on the number of Actos filings in the federal litigation was presented at a May 23rd status conference, which also addressed troubles associated to the status of discovery and the scheduling of bellwether trials in the litigation. Lawsuits filed in this proceeding allege the possible for long-term use of Actos, a type two diabetes drug manufactured by Takeda Pharmaceuticals, to trigger or worsen bladder cancer. (In re: Actos Solution Liability Litigation, MDL No. 2299)

As we continue to receive inquiries about prospective Actos lawsuits from individuals who allege extended-term use of the drug triggered their bladder cancer, we are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and health-related devices. The Firm is at the moment offering free Actos bladder cancer lawsuit evaluations to individuals who developed bladder cancer right after utilizing the medication for an extended period of time.

Actos Bladder Cancer Lawsuit Allegations

The federal multidistrict litigation for Actos bladder cancer lawsuits was produced in the U.S. District Court, Western District of Louisiana in December 2011, after the U.S. Meals and Drug Administration issued an alert warning the public that long-term use of the medication might increase a individuals threat for establishing bladder cancer.* There are now 1,500 instances pending in in the Western District of Louisiana, exactly where the proceeding continues to move forward. According to court documents, the next status conference in the litigation has been scheduled for June 20, 2013. Court records further indicate the first bellwether trials for the Actos bladder cancer litigation have been scheduled as effectively, with the initial trial is slated to begin on January 27, 2014, with the second to adhere to on April 14, 2014.

In addition to the federal litigation, Bloomberg.com reported on May 1st that claims filed more than the medication employed to manage blood-sugar levels in type 2 diabetes sufferers are pending in state litigations in Illinois and California.**

Individuals who took Actos and developed bladder cancer following lengthy-term use of the drug may possibly be eligible to seek compensation for medical bills, lost wages, pain and suffering and other damages. Understand more about how to file an Actos lawsuit by going to Bernstein Liebhard LLPs web site or by calling a single of the Firms Actos lawyers at 800-511-5092.

*FDA, June 15, 2011 fda.gov/drugs/drugsafety/ucm259150.htm
**bloomberg.com/news/2013-05-01/takeda-gets-six-five-million-diabetes-drug-verdict-thrown-out.html

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, which includes these who have been harmed by harmful drugs, defective health-related devices and customer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous ten consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

Attorney Advertising.
New York, New York (PRWEB) May possibly 30, 2013
Thousands of vaginal mesh lawsuit claims continue to move forward in federal litigations now underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Pretrial Order issued by the Court on May possibly 29th, parties in the litigations have reached an agreement regarding the delayed filing of claims and the application of the statute of limitations. According to the Order, the agreement will apply to 4 litigations underway in the Southern District of West Virginia: American Health-related Systems, Inc., Pelvic Repair Systems Items Liability Litigation (MDL No. 2325) In re: Boston Scientific Corp., Pelvic Repair Systems Items Liability Litigation (MDL No. 2326) In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2187) and In re: Ethicon, Inc., Pelvic Repair Systems Goods Liability Litigation ( MDL No. 2327). Bernstein Liebhard LLP partner, Jeffrey S. Grand, serves on the Plaintiffs Steering Committee in all of these proceedings.

This Order will make certain that vaginal mesh lawsuits are filed in an effective manner in these 4 proceedings. We are pleased to see these situations progressing, as we continue to hear from ladies who allegedly suffered significant vaginal mesh complications following surgery to treat pelvic organ prolapse and pressure urinary incontinence, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and health-related devices. The Firm is at present representing hundreds of girls in state and federal courts who allegedly suffered mesh erosion, pain, scarring, infection and other serious vaginal mesh complications.

Vaginal Mesh Complications
Pelvic mesh devices employed to treat pelvic organ prolapse and pressure urinary incontinence have been the topic of a U.S. Meals & Drug Administration (FDA) security assessment because October 2008, when the agency warned that it had received more than 1,000 vaginal mesh complication reports for the duration of a 3-year period. In July 2011, the FDA changed its stance on the frequency of injuries associated with prolapse repair, stating it no longer regarded these complications to be rare. At that time, the agency revealed it had received far more than two,800 reports of vaginal mesh injuries because its 2008 communication.*

Court documents indicate that thousands of women have given that filed transvaginal mesh lawsuits, all of which allege the manufacturers of the devices have been negligent in designing the items, and failed to warn customers of their significant risks. Thousands of added transvaginal mesh claims involving goods marketed by Ethicon Inc. and C.R. Bard have been consolidated in New Jersey Superior Court, Atlantic County, exactly where Bernstein Liebhard LLP partner, Jeffrey, S.. Grand is serving as Co-Liaison Counsel. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-ten, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-ten) He also served on the trial team in the litigations initial Ethicon mesh trial, which concluded with an award of far more than $ 11 million, including punitive damages, to the Plaintiff. (Gross v. Gynecare Inc., Atl-L-6966-ten, Superior Court of Atlantic County, New Jersey).

Victims of alleged vaginal mesh complications could be entitled to compensation for their healthcare bills, discomfort and suffering, and other injuries. A wealth of info relating to transvaginal mesh lawsuits can be located at Bernstein Liebhard’s web site. To learn a lot more, please get in touch with 800-511-5092.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm

About Bernstein Liebhard LLP 
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide since 1993, which includes these who have been harmed by unsafe drugs, defective health-related devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the past ten consecutive years.

Bernstein Liebhard LLP 
ten East 40th Street 
New York, New York 10016 
800-511-5092

Lawyer Marketing.
Newport Beach, CA (Vocus/PRWEB) March 31, 2011
Thanks to Brookstone Law, PCs Emergency Extension Department (EED), a new resource to help homeowners facing foreclosure keep their homes, two local seniors have kept their home despite their Banks attempts to hide the sale date from them, it was announced today by Vito Torchia, Jr., managing attorney of Brookstone Law, PC.
According to court documents, Bob and Angela Sacchi, a married couple in their 80s living on a fixed pension income and savings in West Hollywood, CA, were facing foreclosure, the sale of their home and eventual eviction based on a predatory home loan they obtained in 2004 and the banks refusal to allow them to modify their mortgage despite numerous attempts to fix their problems over the past several years. The case is Sacchi, vs. MERS et al., Case No. CV 11-01658 pending in the United States District Court – Central District of California.
After initially stopping the sale of their home the day before it was scheduled to be sold, Brookstone Law continued to represent the couple. Unbeknownst to either the Sacchis or Brookstone Law, a new sale date was scheduled by the Bank. Only through Brookstone Laws attention to detail and frequent follow up did the EED team discover the Bank had scheduled a new sale date.
When our EED team helps achieve a postponement, we always look for the opportunity to pursue additional actions to extend postponements or achieve cancellations, said Aalok Sikand, one of the lead attorneys on the EED team. We learned through our hard work and research that the Bank had set a new sale date and were not surprised to discover they had not communicated that to the Sacchis.
Brookstone immediately prepared and filed an ex parte motion for a temporary restraining order and for an order setting a hearing date for a preliminary injunction against certain of the foreclosing defendants. According to court documents, the motion was based on alleged violations of California foreclosure statutes and on a securitization audit and accompanying affidavit calling into question the authority of the foreclosing party to actually foreclose. The Court issued the temporary restraining order, restraining all defendants from foreclosing on the Sacchis home pending a hearing on the preliminary injunction. The Court will set a briefing schedule.
Thanks to Brookstone Laws EED we have a sense of security about our future, said Mr. Sacchi, a member of the Screen Actors Guild and American Federation of Radio and Television Artists who starred in the film “The Man Who Stole Bogart’s Face” and has appeared in numerous popular television series including “Kojak” and “Fantasy Island.” Brookstone Law said they would fight for us in court and they did just that.
Like many homeowners, the couple had heard stories about how homeowners facing foreclosure are treated by banks and how many banks do not allow short sales to address foreclosures. Media reports have highlighted banks mishandling of mortgage foreclosures and mistreating consumers, practices which have led to legal action throughout the country including suits filed by more than 40 state attorneys general against banks and lenders. Media coverage has shown banks throwing peoples belongings into the street in wrongful evictions, overcharging thousands of members of the military on their mortgages and bank executives admitting to blatant misadministration of loan documents in wrongful foreclosure trials.
Facing immediate foreclosure, without opportunity for a loan modification, living on a fixed low income and with nowhere to go if their home was sold, there seemed to be no way for the couple to stop their initial foreclosure until they contacted the EED specialists at Brookstone Law. EEDs team of legal experts and specialists acted decisively and fought for the couple in court by filing a lawsuit that resulted in a postponement of the first sale date.
This is another example of how we will not stop working until we achieve the results our clients need, said Nisha S., a seasoned EED specialist. Without dedicated attorneys and specialists working on their behalf, the Sacchis would not have known about the difficult situation the bank put them in before it was too late for them to act to save their home.
At a time when millions of Americans are losing their homes as part of the foreclosure crisis, homeowners face a daunting challenge when dealing with banks. To deal with those challenges, many homeowners have turned to the EED help them keep their homes. Created by Brookstone Law to help consumers deal directly with an institutional bureaucracy that is biased against them, the EED is a unique service not offered by any other firm that gives homeowners facing foreclosure a fighting chance to keep their homes. Brookstone Laws EED attorneys and specialists are experienced in working directly with banks and extensively trained to help homeowners achieve postponements.
Brookstone Laws legal team researches all available options to assist homeowners extend their sale date while they are in the process of litigation, bankruptcy or short sale. Fees are contingent upon success of the service, which means consumers pay only if the sale can be postponed or stopped. Homeowners facing foreclosure like the Sacchis are using the EED to help keep their homes. The process typically takes several hours per client and many cases require as much as a full day to get results since a majority of EED activity is spent by the Firms lawyers and experts in foreclosure law and litigation dealing directly and negotiating with banks and lenders.
“We will not hesitate to go to court if necessary to get the results we need, which is where our team of legal experts and attorneys is of greatest value to homeowners seeking relief, said Vito Torchia, Jr. Our EED legal team and specialists are to be commended once again for doing such great work on behalf of a deserving couple.
About Brookstone Law, PC
Headquartered in Newport Beach, Calif., and with offices in Los Angeles, Calif., and Ft. Lauderdale, Fla., Brookstone Law, PC is a law firm comprised of attorneys with experience and success in business, corporate and personal finance, employment, entertainment and media, art and museum, intellectual property and real estate law. The firm has a network of more than 40 affiliate attorneys nationwide and employs highly trained specialists, paralegals, paraprofessionals and administrative staff dedicated to serving clients. For information, call (800) 946-8655 or visit Brookstone-Law.com (http://www.brookstone-law.com).
# # #
New York, New York (PRWEB) May 26, 2013
The federal litigation established for Biomet hip lawsuits continues to move forward in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to the Courts website, the litigations next Case Management Conference has been scheduled for June 17th. All of the lawsuits pending in the Biomet hip replacement litigation allege the metal-on-metal design of the Biomet M2a Magnum hip can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation MDL No. 2391)
Our Firm is already representing clients in the federal Biomet hip replacement litigation, and continues to receive inquiries from Biomet M2a hip recipients who have allegedly suffered serious and debilitating complications related to the metal-on-metal device. We are pleased to see this proceeding moving forward, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free Biomet hip lawsuit evaluations to individuals allegedly injured by the Biomet M2a hip.
Biomet Hip Lawsuits
Biomet M2a Magnum Hip Replacements are metal-on-metal hip implants, which consist of a ball and cup made from a chromium-cobalt alloy. As of March 2013, court documents indicated that more than 140 Biomet hip lawsuits were pending in the federal Biomet hip replacement litigation. All federally-filed Biomet hip lawsuits were ordered transferred to the Northern District of Indiana in October 2012, in anticipation of a large number of claims.
This past January, the U.S. Food & Drug Administration (FDA) warned that metal debris shed as metal-on-metal hip components wear may accumulate to dangerous levels in the body. This occurrence can result in bone and/or soft tissue damage in the area surrounding the implant and joint, leading to adverse local tissue reactions, premature device failure, and even additional symptoms or illnesses elsewhere in the body. Among other things, the FDA cautioned doctors to consider metal ion testing if patients are experiencing symptoms of hip implant failure. According to the January announcement, the FDA is considering implementing new regulations for metal-on-metal hip implants that would make the devices ineligible for 510(k) clearances, which allowed such implants to come to market without human clinical trials.*
Alleged victims of Biomet hip replacement problems, including metallosis, hip implant failure, and other serious complications may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhards website. For additional information, please contact one of our attorneys today by calling 800-511-5092.
*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092
ATTORNEY ADVERTISING.
New York, New York (PRWEB) May 25, 2013
Pradaxa lawsuits filed on behalf of patients who allegedly suffered serious, life-threatening episodes of internal bleeding while using the blood thinner continue to mount in a federal litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to a posting on the Courts website, 818 Pradaxa side effect claims had been filed in the litigation as of May 24, 2013. Thats up from 705 claims reported by the Court on May 15th. ( In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation MDL No. 2385)
We are not surprised that the Pradaxa lawsuits filed in this litigation are increasing at such a rapid rate. Our Firm receives inquiries on a regular basis from Pradaxa patients who have allegedly suffered serious instances of internal bleeding, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Pradaxa side effect lawsuit evaluations to anyone who suffered internal bleeding while using the blood thinner.
Pradaxa Side Effects
Plaintiffs with claims pending in the Pradaxa side effect litigation allege that Boehringer Ingelheim failed to adequately warn that there is no readily-available antidote for internal bleeding that is sometimes associated with use of the blood thinner. According to a Bloomberg.com report published in December 2012, regulators in several countries have issued alerts regarding Pradaxas potential to cause dangerous internal bleeding in some patients.* Pradaxa was supposed to be an improvement over warfarin, a decades old blood thinner. However, warfarin bleeding can be stopped via the administration of vitamin K, while dialysis is the only available treatment for this Pradaxa side effect.
(PRWEB) May 25, 2013
Dr. Art Stellar, to head NEFs Midwest and Southern region federal grants/ STEM Academy division. We are tremendously excited about Arts plans for our federal grants and STEM Academy programs commented NEFS Chairman Dr. Appu Kuttan. Stellars primary role is to aid school districts across the United States (specifically KS, MO, IL, TN, GA, MS, & FL) apply for and receive funding through the Federal Qualified Zone Academy Bonds (QZAB) program (http://www.qzab.org).
Each state has millions of dollars available with most being currently unclaimed. This funding is first come, first served and may not exist in the future if left unused or not utilized according to the Federal requirements. Interested school administrators should contact Dr. Stellar (828-764-1785 or artstellar(at)yahoo(dot)com)
Stellar brings a broad range of educational experience to NEF. He has served as superintendent of school districts in various states, as well as being a central office administrator, principal, coach, and teacher. Dr. Stellar has also been active in numerous professional organizations including being elected president of Association for Supervision and Curriculum Development, the North American Chapter of the World Council for Curriculum and Instruction and the Horace Mann League. He was also elected vice-president of the New York State PTA and chairman of the Board for the National Dropout Prevention Center at Clemson University.
We selected Dr. Stellar for this role due to his passion for better education for our disadvantaged students, wide range of contacts, knowledge of education and ability to communicate, along with his track record of getting things done, stated Dr. Appu Kuttan, founder and president of the National Education Foundation. He continued, Our mission is to help raise student achievement by assisting school districts access funds while ensuring that they meet all the requirements of QZAB.
About NEF: The National Education Foundation (NEF) is the national nonprofit leader in bridging the STEM education divides. As part of its mission, NEF assists school districts with Qualified Zone Academy Bonds (QZAB) funding at the request of the US Congress and the US Education Department. The National Education Foundation has been working with both and the state QZAB directors on QZAB since the inception of the QZAB in 1998. The Foundation is based in Alexandria, Virginia and can be reached at http://www.cyberlearning For information on QZAB, visit http://www.qzab.org.
Gainesville, FL (PRWEB) May 16, 2013
Chris Doering Mortgage advises Florida homeowners on impending FHA changes.
The Federal Housing Administration has made six changes to its mortgage insurance premiums over the last six years. Each modification has increased the short-term cost of using FHA-backed mortgages. The agency’s next change, however, will change its long-term costs.
Beginning on June 3, the FHA will change its long-standing Annual MIP Cancellation Policy. Certain homeowners will lose their right to cancel the annual MIP. Currently, the Federal Housing Administration requires homeowners to pay annual MIP so long as their loan-to-value is greater than 78 percent, where “value” is equal to the last known value of the home. In addition, if the original mortgage term is greater than 15 years, at least 60 payments must have been made on the mortgage before FHA MIP can be automatically cancelled.
Beginning in June, the FHA will move away from an LTV-based system. The new cancellation policy will be as follows: loans beginning at 90 percent LTV or less will pay annual MIP for 11 years and loans beginning at 90 percent LTV or more will pay annual MIP for the complete loan term. This means that home buyers using the Federal Housing Administration’s 3.5 percent down payment program will pay annual mortgage insurance for the loan’s full 30 years, regardless of whether the home appreciates to the point of having 22 percent equity or more.
Chris Doering Mortgage advises any potential Florida FHA borrowers to apply for an FHA loan at least ten days prior to the June 3 deadline, so they may still reap many of the programs benefits by obtaining an FHA case number.
For more information call the mortgage professionals at Chris Doering Mortgage today at 352-244-0840.
About the company:
Established in April 2007, Chris Doering Mortgage opened its doors in the Jacksonville, FL community with the goal of providing exceptional mortgage lender services, and accountability to a mortgage industry that can be both intimidating and overwhelming for potential customers in the market for home loans.
The commitment to skillfully and ethically deliver the highest quality customer service throughout the mortgage process is second to none with the Chris Doering Mortgage team of professionals. They specialize in FHA loans, current mortgage rates and mortgage refinance options.
The staff is constantly educating themselves on the ever-changing home mortgage landscape and adapting to the changing needs of the real estate industry to meet the expectations of clients. For more information visit their website at http://www.mygatormortgage.com.